+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CorMedix Inc - logo

CorMedix Inc - Company & Market Research Reports

Following a company allows Research and Markets to customize your experience and provide personalized recommendations.

CorMedix is a commercial-stage pharmaceutical company focused on the treatment of infectious, inflammatory, and other serious diseases. The company markets Neutrolin, a catheter lock solution for the prevention of catheter related bloodstream infections. Neutrolin is approved as a CE Marked medical device in Europe where it was shown to reduce catheter-related bloodstream infections by 96% and thrombosis by 96.7%. Founded in 2006, it is based in Bridgewater, New Jersey.

Neuroblastoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 543 Pages
From
Neuroblastoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Neuroblastoma - Pipeline Review, H2 2017

  • Drug Pipelines
  • 506 Pages
From
From
Osteosarcoma - Pipeline Review, H1 2019 - Product Thumbnail Image

Osteosarcoma - Pipeline Review, H1 2019

  • Drug Pipelines
  • 625 Pages
From
From
Osteosarcoma - Pipeline Insight, 2019 - Product Thumbnail Image

Osteosarcoma - Pipeline Insight, 2019

  • Drug Pipelines
  • 50 Pages
From
From
From
From
From
From
Cormedix Incorporation - Product Thumbnail Image

Cormedix Incorporation

  • Company Profile
  • 74 Pages
  • 17 Results (Page 1 of 1)
Loading Indicator
adroll